CCR Translation for This Article from Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
收藏NIAID Data Ecosystem2026-05-16 收录
下载链接：
https://figshare.com/articles/dataset/CCR_Translation_for_This_Article_from_Phase_II_Open-Label_Study_of_Brivanib_as_Second-Line_Therapy_in_Patients_with_Advanced_Hepatocellular_Carcinoma/22444149
下载链接
链接失效反馈官方服务：
资源简介：
CCR Translation for This Article from Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
创建时间：
2012-04-01
